DK1077718T3 - Forøgelse af aktiviteten af antibakterielle oxazolidinon-midler ved anvendelse af argininderivater - Google Patents

Forøgelse af aktiviteten af antibakterielle oxazolidinon-midler ved anvendelse af argininderivater

Info

Publication number
DK1077718T3
DK1077718T3 DK99921365T DK99921365T DK1077718T3 DK 1077718 T3 DK1077718 T3 DK 1077718T3 DK 99921365 T DK99921365 T DK 99921365T DK 99921365 T DK99921365 T DK 99921365T DK 1077718 T3 DK1077718 T3 DK 1077718T3
Authority
DK
Denmark
Prior art keywords
agents
activity
increase
arginine derivatives
antibacterial oxazolidinone
Prior art date
Application number
DK99921365T
Other languages
Danish (da)
English (en)
Inventor
Michael John Bohanon
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK1077718T3 publication Critical patent/DK1077718T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99921365T 1998-05-18 1999-05-13 Forøgelse af aktiviteten af antibakterielle oxazolidinon-midler ved anvendelse af argininderivater DK1077718T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8116498A 1998-05-18 1998-05-18
PCT/US1999/007038 WO1999059616A1 (en) 1998-05-18 1999-05-13 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives

Publications (1)

Publication Number Publication Date
DK1077718T3 true DK1077718T3 (da) 2002-11-11

Family

ID=22162494

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99921365T DK1077718T3 (da) 1998-05-18 1999-05-13 Forøgelse af aktiviteten af antibakterielle oxazolidinon-midler ved anvendelse af argininderivater

Country Status (25)

Country Link
US (1) US6251869B1 (no)
EP (1) EP1077718B1 (no)
JP (1) JP2002515450A (no)
KR (1) KR20010043695A (no)
CN (1) CN1170584C (no)
AT (1) ATE222115T1 (no)
AU (1) AU746606B2 (no)
BR (1) BR9910443A (no)
CA (1) CA2327100A1 (no)
CZ (1) CZ291945B6 (no)
DE (1) DE69902526T2 (no)
DK (1) DK1077718T3 (no)
EA (1) EA003458B1 (no)
ES (1) ES2182521T3 (no)
HK (1) HK1036222A1 (no)
HU (1) HUP0101958A3 (no)
IL (1) IL139437A0 (no)
NO (1) NO20005813D0 (no)
NZ (1) NZ508256A (no)
PL (1) PL344049A1 (no)
PT (1) PT1077718E (no)
SK (1) SK283038B6 (no)
TR (1) TR200003384T2 (no)
WO (1) WO1999059616A1 (no)
ZA (1) ZA200005923B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
GB0005703D0 (en) 2000-03-09 2000-05-03 Alpharma As Compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
US20050255538A1 (en) * 2002-03-15 2005-11-17 Buxser Stephen E Methods for screening for AcrAB efflux pump inhibitors
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
CN1976703A (zh) * 2004-06-30 2007-06-06 诺瓦提斯公司 通过使用外排泵抑制剂增加肽脱甲酰基酶抑制剂敏感性的方法
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
AU2006299126B2 (en) 2005-10-04 2012-06-28 Bayer Intellectual Property Gmbh Novel polymorphous form and the amorphous form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
SG11201701928RA (en) 2014-09-12 2017-04-27 Antibiotx Aps Antibacterial use of halogenated salicylanilides
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
WO2020176067A1 (en) 2019-02-25 2020-09-03 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with h. pylori using a halogenated salicylanilide
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989832A (en) * 1995-04-21 1999-11-23 Microcide Pharmaceuticals, Inc. Method for screening for non-tetracycline efflux pump inhibitors
AU729745B2 (en) * 1997-07-11 2001-02-08 Pharmacia & Upjohn Company Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents
US6068972A (en) * 1997-10-03 2000-05-30 Trustees Of Tufts College Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solvents
US6790856B2 (en) * 2002-01-31 2004-09-14 Boehringer Ingelheim Pharma Kg Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments

Also Published As

Publication number Publication date
BR9910443A (pt) 2001-01-02
CN1170584C (zh) 2004-10-13
NZ508256A (en) 2003-08-29
KR20010043695A (ko) 2001-05-25
JP2002515450A (ja) 2002-05-28
CN1297355A (zh) 2001-05-30
WO1999059616A1 (en) 1999-11-25
SK283038B6 (sk) 2003-02-04
ES2182521T3 (es) 2003-03-01
EA003458B1 (ru) 2003-06-26
NO20005813L (no) 2000-11-17
US6251869B1 (en) 2001-06-26
SK16252000A3 (sk) 2001-06-11
EP1077718B1 (en) 2002-08-14
ATE222115T1 (de) 2002-08-15
AU3860199A (en) 1999-12-06
IL139437A0 (en) 2001-11-25
ZA200005923B (en) 2001-10-23
CZ20004259A3 (en) 2001-05-16
PL344049A1 (en) 2001-09-24
EA200001197A1 (ru) 2001-04-23
DE69902526D1 (de) 2002-09-19
DE69902526T2 (de) 2003-04-03
TR200003384T2 (tr) 2001-03-21
HUP0101958A2 (hu) 2001-10-28
CZ291945B6 (cs) 2003-06-18
CA2327100A1 (en) 1999-11-25
AU746606B2 (en) 2002-05-02
NO20005813D0 (no) 2000-11-17
EP1077718A1 (en) 2001-02-28
HK1036222A1 (en) 2001-12-28
HUP0101958A3 (en) 2003-07-28
PT1077718E (pt) 2002-12-31

Similar Documents

Publication Publication Date Title
DK1077718T3 (da) Forøgelse af aktiviteten af antibakterielle oxazolidinon-midler ved anvendelse af argininderivater
EA199900620A1 (ru) Фталазиноны
ES2182234T3 (es) Inhibidores de metaloproteasa.
PT1140993E (pt) Derivados de glicopeptidos e composicoes farmaceuticas contendo os mesmos
EA200300566A1 (ru) Применение cci-779 в качестве противоопухолевого средства
NO995846D0 (no) Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet
BR9908004A (pt) Composto, composição e método para prevençãoou supressão de uma infecção viral
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
UY27909A1 (es) Composicion herbicida
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
EA199900421A1 (ru) Бензонафтиридины в качестве бронхиальных терапевтических средств
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
EA200200699A1 (ru) Оксазолидиноны, обладающие сульфоксиминовой функциональностью
HRP20050517B1 (hr) N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
DE60042401D1 (de) Fab-i inhibitoren
DE69936052D1 (de) N1 modifizierte glycopeptide
EA200000092A1 (ru) Противоаллергические средства
ATE403655T1 (de) Imidazopyridinderivate als induzierbare no- synthaseinhibitoren
EA200000697A1 (ru) ПРОИЗВОДНЫЕ БЕНЗО[C]ХИНОЛИЗИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ 5α-РЕДУКТАЗ
BR0313400A (pt) N-aril-2-oxazolidinonas e seus derivados
LV12375A (lv) 1-(3-aminoindazol-5-il)-fenilmetil)-cikliskas urinvielas piemerotas ka HIV proteazes inhibitori
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
ECSP993176A (es) Nuevos compuestos y composiciones antibacterianas
EA200501830A1 (ru) Новые производные линкомицина, обладающие антимикробной активностью